Non-invasive Cardiac Activation Mapping and Identification of Severity of Epicardial Substrate in Brugada Syndrome: a Case Report

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2024 Feb 9

PMID 38333419

Authors

Saverio Iacopino

Paolo Sorrenti

Giuseppe Campagna

Gennaro Fabiano

Emmanuel Fabiano

Jacopo Colella

Affiliations

Soon will be listed here.

Abstract

Introduction: It has recently been shown that electrocardiographic imaging (ECGi) can be employed in individuals undergoing an ajmaline test who have Brugada Syndrome (BrS), to evaluate the extent of substrate-involved arrhythmia in the right ventricular overflow tract (RVOT). For the first time, we stratify the risk of sudden cardiac death (SCD) in BrS during ajmaline testing using the dST-Tiso interval (a robust predictor of the inducibility of ventricular arrhythmias (VAs) in the presence of drug-induced BrS type-1 pattern) in combination with ECGi technology.

Case Presentation: We studied a 48-year-old man with BrS ECG type-2 pattern and presence of J-wave without a family history of SCD but with a previous syncope. Transthoracic echocardiography and cardiac magnetic resonance imaging were performed, showing normal results. The ECG was performed to assess the novel ECG marker "dST-Tiso interval." The 3D epicardial mapping of the RVOT surface was performed with the support of a non-contact cardiac mapping system in sinus rhythm during ajmaline infusion. The examination of the propagation map unveiled the presence of multiple conduction blocks in this pathologic epicardial region, and the conduction blocks were identified within the central part and/or near the boundary separating the normal and slow conduction areas.

Conclusion: The dST-Tiso interval, which lies between the onset and termination of the coved ST-segment elevation and serves as a robust predictor of VA inducibility in cases of drug-induced BrS type-1 pattern, was utilized in conjunction with ECGi technology (employed for the non-invasive confirmation and identification of the pathological substrate area). This combined approach was applied to stratify the risk of SCD in BrS during ajmaline testing, alongside clinical scores.

References

Iacopino S, Chierchia G, Sorrenti P, Pesce F, Colella J, Fabiano G . dST-Tiso Interval, a Novel Electrocardiographic Marker of Ventricular Arrhythmia Inducibility in Individuals With Ajmaline-Induced Brugada Type I Pattern. Am J Cardiol. 2021; 159:94-99. DOI: 10.1016/j.amjcard.2021.08.014. View

Sieira J, Conte G, Ciconte G, Chierchia G, Casado-Arroyo R, Baltogiannis G . A score model to predict risk of events in patients with Brugada Syndrome. Eur Heart J. 2017; 38(22):1756-1763. DOI: 10.1093/eurheartj/ehx119. View

Masse S, Magtibay K, Jackson N, Asta J, Kusha M, Zhang B . Resolving Myocardial Activation With Novel Omnipolar Electrograms. Circ Arrhythm Electrophysiol. 2016; 9(7):e004107. PMC: 4956680. DOI: 10.1161/CIRCEP.116.004107. View

Lambiase P, Ahmed A, Ciaccio E, Brugada R, Lizotte E, Chaubey S . High-density substrate mapping in Brugada syndrome: combined role of conduction and repolarization heterogeneities in arrhythmogenesis. Circulation. 2009; 120(2):106-17, 1-4. DOI: 10.1161/CIRCULATIONAHA.108.771401. View

Brugada P, Geelen P, Brugada R, Mont L, Brugada J . Prognostic value of electrophysiologic investigations in Brugada syndrome. J Cardiovasc Electrophysiol. 2001; 12(9):1004-7. DOI: 10.1046/j.1540-8167.2001.01004.x. View

Priori S, Gasparini M, Napolitano C, Della Bella P, Ghidini Ottonelli A, Sassone B . Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry. J Am Coll Cardiol. 2011; 59(1):37-45. DOI: 10.1016/j.jacc.2011.08.064. View

Kawada S, Morita H, Antzelevitch C, Morimoto Y, Nakagawa K, Watanabe A . Shanghai Score System for Diagnosis of Brugada Syndrome: Validation of the Score System and System and Reclassification of the Patients. JACC Clin Electrophysiol. 2018; 4(6):724-730. DOI: 10.1016/j.jacep.2018.02.009. View

Iacopino S, Cecchini F, Tripodi A, Sorrenti P, Fabiano G, Petretta A . Epicardial multisite conduction blocks detected by equispaced electrode array and omnipolar technology in Brugada syndrome. HeartRhythm Case Rep. 2023; 9(1):12-16. PMC: 9845549. DOI: 10.1016/j.hrcr.2022.09.015. View

Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel B, Behr E, Blom N . 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022; 43(40):3997-4126. DOI: 10.1093/eurheartj/ehac262. View

10.

Salghetti F, de Asmundis C, Sieira J, Coutino H, Abugattas J, Varnavas V . Hybrid thoracoscopic epicardial ablation of right ventricular outflow tract in patients with Brugada syndrome. Heart Rhythm. 2018; 16(6):879-887. DOI: 10.1016/j.hrthm.2018.12.026. View

11.

Haissaguerre M, Nademanee K, Sacher F, Cheniti G, Hocini M, Surget E . Multisite conduction block in the epicardial substrate of Brugada syndrome. Heart Rhythm. 2021; 19(3):417-426. DOI: 10.1016/j.hrthm.2021.10.030. View

12.

Priori S, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J . 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the.... Eur Heart J. 2015; 36(41):2793-2867. DOI: 10.1093/eurheartj/ehv316. View

13.

Szel T, Antzelevitch C . Abnormal repolarization as the basis for late potentials and fractionated electrograms recorded from epicardium in experimental models of Brugada syndrome. J Am Coll Cardiol. 2014; 63(19):2037-45. PMC: 4024366. DOI: 10.1016/j.jacc.2014.01.067. View

14.

Pannone L, Monaco C, Sorgente A, Vergara P, Calburean P, Gauthey A . Ajmaline-Induced Abnormalities in Brugada Syndrome: Evaluation With ECG Imaging. J Am Heart Assoc. 2022; 11(2):e024001. PMC: 9238512. DOI: 10.1161/JAHA.121.024001. View

15.

Nademanee K, Veerakul G, Chandanamattha P, Chaothawee L, Ariyachaipanich A, Jirasirirojanakorn K . Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation. 2011; 123(12):1270-9. DOI: 10.1161/CIRCULATIONAHA.110.972612. View

16.

Pappone C, Brugada J, Vicedomini G, Ciconte G, Manguso F, Saviano M . Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome. Circ Arrhythm Electrophysiol. 2017; 10(5):e005053. DOI: 10.1161/CIRCEP.117.005053. View

17.

Haissaguerre M, Cheniti G, Nademanee K, Sacher F, Duchateau J, Coronel R . Dependence of epicardial T-wave on local activation voltage in Brugada syndrome. Heart Rhythm. 2022; 19(10):1686-1688. DOI: 10.1016/j.hrthm.2022.05.036. View

18.

Porta-Sanchez A, Magtibay K, Nayyar S, Bhaskaran A, Lai P, Masse S . Omnipolarity applied to equi-spaced electrode array for ventricular tachycardia substrate mapping. Europace. 2019; 21(5):813-821. PMC: 6479413. DOI: 10.1093/europace/euy304. View